Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and titanium dioxide

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with titanium dioxide in 1 studies

Compound Research Comparison

Studies
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)
Trials
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)
Recent Studies (post-2010)
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)
Studies
(titanium dioxide)
Trials
(titanium dioxide)
Recent Studies (post-2010) (titanium dioxide)
6383124313,378658,839

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bergan, RC; Dharmakumar, R; Ke, T; Lai, B; Larson, A; Li, D; Lu, ZR; Mascheri, N; Maser, J; Omary, R; Paunesku, T; Szolc-Kowalska, B; Thurn, K; Vogt, S; Woloschak, GE; Wu, A1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and titanium dioxide

ArticleYear
Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images.
    Nanomedicine : nanotechnology, biology, and medicine, 2008, Volume: 4, Issue:3

    Topics: Cell Line, Tumor; Contrast Media; Dopamine; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Nanostructures; Oligonucleotides; Organometallic Compounds; Polyglutamic Acid; Titanium

2008